0

531592

GENPHARMA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GENPHARMASEC LIMITED Share Price Today

Investment Returns

Over 1 Month -1.72% Over 3 Months 23.91% Over 6 Months -12.97% Over 1 Year -44.39%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GENPHARMASEC LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 63.10
  • P/E Ratio (TTM) 11.40
  • Beta 1.06
  • Book Value / share 1.29
  • Return on equity 3.59%
  • EPS (TTM) 0.10
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 2.32
info icon alternate text

GENPHARMASEC LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 51.66
Operating Expense 50.42
Net Profit 2.32
Net Profit Margin (%) 4.49
Earnings Per Share (EPS) 0.04
EBITDA 3.19
Effective Tax Rate (%) 18.88
Particulars DEC 2025 (Values in Cr)
Revenue 36.01
Operating Expense 36.94
Net Profit 0.76
Net Profit Margin (%) 2.11
Earnings Per Share (EPS) 0.01
EBITDA 0.75
Effective Tax Rate (%) -55.10
Particulars SEP 2025 (Values in Cr)
Revenue 31.56
Operating Expense 31.18
Net Profit 0.82
Net Profit Margin (%) 2.59
Earnings Per Share (EPS) 0.01
EBITDA 1.50
Effective Tax Rate (%) 40.57
Particulars JUN 2025 (Values in Cr)
Revenue 12.11
Operating Expense 11.23
Net Profit 1.56
Net Profit Margin (%) 12.88
Earnings Per Share (EPS) 0.03
EBITDA 1.83
Effective Tax Rate (%) 8.77
Particulars MAR 2025 (Values in Cr)
Revenue 13.56
Operating Expense 14.65
Net Profit -0.23
Net Profit Margin (%) -1.69
Earnings Per Share (EPS) 0.01
EBITDA 0.06
Effective Tax Rate (%) -475.00
Particulars MAR 2026 (Values in Cr)
Revenue 131.35
Operating Expense 129.78
Net Profit 5.45
Net Profit Margin (%) 4.14
Earnings Per Share (EPS) 0.10
EBITDA 7.29
Effective Tax Rate (%) 15.37
Particulars MAR 2025 (Values in Cr)
Revenue 32.96
Operating Expense 32.62
Net Profit 2.80
Net Profit Margin (%) 8.49
Earnings Per Share (EPS) 0.04
EBITDA 4.18
Effective Tax Rate (%) 25.92
Particulars MAR 2024 (Values in Cr)
Revenue 30.41
Operating Expense 30.65
Net Profit 0.05
Net Profit Margin (%) 0.16
Earnings Per Share (EPS) -0.01
EBITDA 0.88
Effective Tax Rate (%) 89.36
Particulars MAR 2023 (Values in Cr)
Revenue 25.52
Operating Expense 25.34
Net Profit 1.12
Net Profit Margin (%) 4.38
Earnings Per Share (EPS) 0.04
EBITDA 0.36
Effective Tax Rate (%) -299.99
Particulars MAR 2022 (Values in Cr)
Revenue 27.32
Operating Expense 27.86
Net Profit -0.21
Net Profit Margin (%) -0.76
Earnings Per Share (EPS) -0.01
EBITDA -0.43
Effective Tax Rate (%) 52.27
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1.18
ROE % 1.85
ROCE % 3.28
Total Debt to Total Equity 0.07
EBITDA Margin 9.31
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin 2.30
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.55
ROE % 5.63
ROCE % 1.48
Total Debt to Total Equity 0.20
EBITDA Margin 1.41
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1.20
ROE % 3.59
ROCE % 5.18
Total Debt to Total Equity 0.05
EBITDA Margin 11.74
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.17
ROE % 0.11
ROCE % 1.81
Total Debt to Total Equity 0.08
EBITDA Margin 2.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.55
ROE % 6.35
ROCE % 1.77
Total Debt to Total Equity 0.10
EBITDA Margin 1.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.56
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -1.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.75
ROE % 6.35
ROCE % 7.61
Total Debt to Total Equity 0.00
EBITDA Margin 7.13
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.27
Total Assets 79.89
Total Liabilities 79.89
Total Equity 65.27
Share Outstanding 55
Price to Book Ratio 1.58
Return on Assets (%) 1.54
Return on Capital (%) 1.8
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 18.83
Total Assets 71.12
Total Liabilities 71.12
Total Equity 64.53
Share Outstanding 55
Price to Book Ratio 1.91
Return on Assets (%) -0.23
Return on Capital (%) -0.25
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.99
Total Assets 19.87
Total Liabilities 19.87
Total Equity 15.33
Share Outstanding 27
Price to Book Ratio 5.65
Return on Assets (%) 5.65
Return on Capital (%) 6.11
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.14
Total Assets 79.09
Total Liabilities 79.09
Total Equity 66.54
Share Outstanding 55
Price to Book Ratio 1.58
Return on Assets (%) 3.12
Return on Capital (%) 3.54
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 18.57
Total Assets 70.47
Total Liabilities 70.47
Total Equity 64.56
Share Outstanding 55
Price to Book Ratio 1.91
Return on Assets (%) 0.06
Return on Capital (%) 0.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.99
Total Assets 19.87
Total Liabilities 19.87
Total Equity 15.33
Share Outstanding 27
Price to Book Ratio 5.65
Return on Assets (%) 5.65
Return on Capital (%) 6.11
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.60
Total Assets 21.65
Total Liabilities 21.65
Total Equity 15.36
Share Outstanding 27
Price to Book Ratio 9.82
Return on Assets (%) -0.96
Return on Capital (%) -1.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.53
Total Assets 27.81
Total Liabilities 27.81
Total Equity 20.66
Share Outstanding 27
Price to Book Ratio 10.68
Return on Assets (%) 4.51
Return on Capital (%) 6.09
Particulars MAR 2025 (Values in Cr)
Net Income 1.88
Cash from Operations 3.06
Cash from Investing -15.29
Cash from Financing -1.24
Net change in Cash -13.56
Free Cash Flow 8.76
Particulars MAR 2024 (Values in Cr)
Net Income 0.25
Cash from Operations -2.90
Cash from Investing -28.06
Cash from Financing 47.84
Net change in Cash 16.83
Free Cash Flow -2.88
Particulars MAR 2023 (Values in Cr)
Net Income 0.28
Cash from Operations -3.32
Cash from Investing 0.36
Cash from Financing 3.08
Net change in Cash 0.38
Free Cash Flow -3.30
Particulars MAR 2025 (Values in Cr)
Net Income 3.44
Cash from Operations 3.49
Cash from Investing -16.45
Cash from Financing -0.43
Net change in Cash -13.43
Free Cash Flow 3.50
Particulars MAR 2024 (Values in Cr)
Net Income 0.46
Cash from Operations -2.23
Cash from Investing -29.03
Cash from Financing 47.89
Net change in Cash 16.58
Free Cash Flow -2.21
Particulars MAR 2023 (Values in Cr)
Net Income 0.28
Cash from Operations -3.32
Cash from Investing 0.36
Cash from Financing 3.08
Net change in Cash 0.38
Free Cash Flow -3.30
Particulars MAR 2022 (Values in Cr)
Net Income -0.44
Cash from Operations -2.31
Cash from Investing 0.41
Cash from Financing 0.00
Net change in Cash -1.92
Free Cash Flow -2.23
Particulars MAR 2021 (Values in Cr)
Net Income 1.50
Cash from Operations -1.78
Cash from Investing -1.41
Cash from Financing 4.50
Net change in Cash 0.95
Free Cash Flow -1.77
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AEGIS LOGISTICS LTD. 1008.40 39.41 5.84 35394.84 576.00 1016.55
KOTHARI INDUSTRIAL CORP L 162.00 0.00 6.98 1749.95 142.00 624.95
OSWAL AGRO MILLS LTD 43.15 0.00 0.64 579.20 33.50 94.50
Dhunseri Ventures Limited 245.05 9.42 0.26 858.17 176.20 386.10
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AEGIS LOGISTICS LTD. 1008.40 37.51 10.23 35394.84 576.00 1016.55
UTIQUE ENTERPRISES LIMITED 4.16 12.24 0.32 23.16 3.20 6.40
COMPUTER POINT LTD. 3.94 0.00 0.35 11.82 3.41 6.56
KOTHARI INDUSTRIAL CORP L 162.00 0.00 6.98 1749.95 142.00 624.95

GENPHARMASEC LIMITED shareholding pattern

Holding
70.02%
29.97%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

GENPHARMASEC LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1.14 0.88 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 1.10
  • 26 Days 1.20
  • 10 Days 1.10
  • 50 Days 1.20
  • 12 Days 1.10
  • 100 Days 1.20
  • 20 Days 1.20
  • 200 Days 1.40
1.14 PIVOT
First Support 1.11 First Resistance 1.15 Second Support 1.10 Second Resistance 1.18 Third Support 1.07 Third Resistance 1.19
RSI 46.05 ADX 8.45 MACD -0.02 Williams % R -61.54 Commodity Channel Index (CCI) -51.27
Date 2026-06-19 Week 159010.00 Same Day 126378.00 Month 360162.00
1 Year 1.06 3 Year 0.84
Over 1 Month
-1.72% down
Over 1 Year
-44.39% down
Over 3 Months
23.91% down
Over 3 Years
-20.04% down
Over 6 Months
-12.97% down
Over 5 Years
-26.70% down

GENPHARMASEC LIMITED Corporate Actions

Ex-Date Old FV NEW FV Record Date
11 Apr 2019 10.0 1.0 12 Apr 2019

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Genpharmasec Ltd?

Answer Field

Genpharmasec Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1.14 as on Jun 19 2026 03:29 PM.

What is the Market Cap of Genpharmasec Ltd Share?

Answer Field

The market cap of Genpharmasec Ltd for NSE ₹ 0.00 & for BSE ₹ 63.10 as on Jun 19 2026 03:29 PM.

What is the 52 Week High and Low of Genpharmasec Ltd?

Answer Field

The 52 Week High and Low of Genpharmasec Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 2.20 and ₹ 0.75.

What is 1 year return for Genpharmasec Ltd?

Answer Field

The 1 year returns on the stock has been -44.39%.

What is the P/E Ratio of Genpharmasec Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM the price-to-earnings (PE) ratio for Genpharmasec Ltd share is 11.40.

What is the PB ratio of Genpharmasec Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM, the price-to-book (PB) ratio for Genpharmasec Ltd share is 1.29.

How to Buy Genpharmasec Ltd Share?

Answer Field

You can trade in Genpharmasec Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Genpharmasec Ltd Share on Bajaj Broking App?

Answer Field

To buy Genpharmasec Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Genpharmasec Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|